You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Haploidentical Transplant

Showing 1 - 25 of 6,600
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematologic Malignancies Trial in Los Angeles (Cyclophosphamide)

Not yet recruiting
  • Hematologic Malignancies
  • Los Angeles, California
    Cedars-Sinai Medical Center
May 5, 2023

Haploidentical Hematopoietic Stem Cell Transplantation Trial in Seoul (ATG-LDPTCy)

Recruiting
  • Haploidentical Hematopoietic Stem Cell Transplantation
  • Seoul, Korea, Republic of
    Samsung Medical Center
Sep 11, 2023

Hematologic Malignancies Trial in Minneapolis (Haplo HCT <55 years old, Haplo HCT =55 years old, GVHD Prophylaxis)

Recruiting
  • Hematologic Malignancies
  • Haplo HCT <55 years old
  • +4 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Jan 25, 2023

Hematologic Malignancy Trial (Cyclophosphamid, ATG)

Not yet recruiting
  • Hematologic Malignancy
  • (no location specified)
Oct 29, 2023

Leukemia, Stem Cell Transplant, Cord Blood Trial in Guangzhou (applying of FLU+CY post-HSCT)

Recruiting
  • Leukemia
  • +2 more
  • applying of FLU+CY post-HSCT
  • Guangzhou, Guangdong, China
    Nanfang Hospital
Nov 23, 2023

Hematological Malignancies Trial (Allogeneic T cell progenitors, cultured ex-vivo)

Not yet recruiting
  • Hematological Malignancies
  • Allogeneic T cell progenitors, cultured ex-vivo
  • (no location specified)
Mar 2, 2023

Leukemia Trial (Donor Enriched Activated Natural Killer Cell Infusion)

Withdrawn
  • Leukemia
  • Donor Enriched Activated Natural Killer Cell Infusion
  • (no location specified)
Dec 20, 2022

Ewing Sarcoma, Neuroblastoma, Rhabdomyosarcoma Trial in Milwaukee (Allogeneic HCT, Donor NK Cell Infusion)

Active, not recruiting
  • Ewing Sarcoma
  • +4 more
  • Allogeneic HCT
  • Donor NK Cell Infusion
  • Milwaukee, Wisconsin
  • +1 more
Apr 5, 2022

Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Recombinant Interleukin-7
  • Houston, Texas
    M D Anderson Cancer Center
Jan 26, 2023

Sickle Cell Anemia Trial run by the NHLBI (PBSC Transplant, Alemtuzumab, Sirolimus)

Active, not recruiting
Has Results
  • Sickle Cell Anemia
  • PBSC Transplant
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 13, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, MDS Trial in Tucson (Bendamustine, Cyclophosphamide)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +12 more
  • Tucson, Arizona
    The University of Arizona Cancer Center
Dec 13, 2022

Transplant-Related Hematologic Malignancy Trial in Atlanta (Sargramostim, Control Arm)

Recruiting
  • Transplant-Related Hematologic Malignancy
  • Atlanta, Georgia
    Northside Hospital
Oct 19, 2022

Recurrent Severe Aplastic Anemia, Refractory Severe Aplastic Anemia Trial in Duarte (biological, procedure, drug, other)

Not yet recruiting
  • Recurrent Severe Aplastic Anemia
  • Refractory Severe Aplastic Anemia
  • Anti-Thymocyte Globulin
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Feb 23, 2023

Multiple Myeloma, CLL, Chronic Lymphocytic Leukemia Trial in Los Angeles (radiation, procedure, biological, drug)

Active, not recruiting
  • Multiple Myeloma
  • +4 more
  • Total Body Irradiation
  • +5 more
  • Los Angeles, California
    Cedars Sinai Medical Center
Dec 21, 2022

Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (haploidentical stem cell transplant,

Recruiting
  • Sickle Cell Disease
  • haploidentical stem cell transplant
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 18, 2022

Sickle Cell Disease Trial in Duarte (Hematopoietic stem cell transplantation)

Recruiting
  • Sickle Cell Disease
  • Hematopoietic stem cell transplantation
  • Duarte, California
    City of Hope Medical Center
Jun 14, 2022

Blood Disease Trial (TCRaß+/CD19+ depleted Hematopoietic stem cell (HSC) graft, CliniMACS® System)

Not yet recruiting
  • Blood Disease
  • TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC) graft
  • CliniMACS® System
  • (no location specified)
Jan 30, 2023

Hematologic Malignancies Trial in La Jolla (Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant)

Suspended
  • Hematologic Malignancies
  • Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant
  • La Jolla, California
    UCSD Medical Center
Jul 20, 2022

Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies Trial in Duarte (Cyclophosphamide, Pentostatin, Rabbit

Recruiting
  • Sickle Cell Disease
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jul 6, 2022

Letermovir Prophylaxis for CMV Infection in Haplo-HSCT

Recruiting
  • CMV Infection
  • Hematopoietic Stem Cell Transplantation
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow university
Mar 29, 2023

Severe Aplastic Anemia Trial in Atlanta (Fludarabine, Cyclophosphamide, Total Body Irradiation)

Recruiting
  • Severe Aplastic Anemia
  • Atlanta, Georgia
  • +1 more
Apr 4, 2022

Hematologic Disorders Trial in Aurora (Miltenyi CliniMACS® CD34 Reagent System)

Recruiting
  • Hematologic Disorders
  • Miltenyi CliniMACS® CD34 Reagent System
  • Aurora, Colorado
    University of Colorado
Feb 22, 2022

Sickle Cell Disease, Thalassemia, High Risk Hematologic Disorders Trial in Minneapolis (Blood and Marrow Transplant)

Recruiting
  • Sickle Cell Disease
  • +4 more
  • Blood and Marrow Transplant
  • Minneapolis, Minnesota
    Masonic Caner Center at University of Minnesota
May 23, 2022

Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute Trial in Boston (radiation, drug, biological,

Recruiting
  • Stem Cell Transplant Complications
  • +4 more
  • Radiation
  • +7 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 19, 2023

Hematological Malignancy Trial in Detroit (Bortezomib)

Recruiting
  • Hematological Malignancy
  • Detroit, Michigan
    Henry Ford hospital
Dec 23, 2021